Clik here to view.
CardioFocus, New Star Lasers settle patent spat
CardioFocus Inc. settled with another defendant in a patent infringement lawsuit it filed in 2008 against nine other firms, accusing them of infringing a trio of patents covering its cardiac laser...
View ArticleCardioFocus zeroes in on $14 million
CardioFocus Inc. pulled in nearly $14 million in a hoped-for $16 million funding round, according to a regulatory filing. The Marlborough, Mass.-based company is developing a visually guided balloon...
View ArticleClik here to view.
CardioFocus reels in $14 million | Funding roundup
CardioFocus Inc. drummed up in nearly $14 million in a hoped-for $15.6 million funding round. The Marlborough, Mass.-based company is developing a visually guided balloon catheter that uses a rotating...
View ArticleClik here to view.
Sleep apnea: ImThera touts tongue stimulation treatment | Research roundup
ImThera Medical Inc. said its tongue stimulation device for sleep apnea can improve patients’ snooze time. The San Diego-based device maker concluded a European pilot study of its aura6000, an...
View ArticleClik here to view.
Venture Capital: Omar Amirana leaves Oxford for Allied Minds
Amirana Omar Amirana, a partner at Oxford Biosciences, a life sciences VC firm that manages more than $1 billion in capital, will be pulling up anchor and moving over to Allied Minds, a “a private...
View ArticleClik here to view.
Wall Street Beat: Goldman Sachs raises COV estimate; Nygren shucks JNJ...
MASSDEVICE WALL STREET ROUNDUP | One of Wall Street’s most notorious names raised its view of Covidien plc (NYSE:COV) today, setting a price target that’s 15 percent above yesterday’s closing price....
View ArticleClik here to view.
CardioFocus launches pivotal trial for HeartLight ablation system
CardioFocus successfully treated the first patient in a pivotal trial of its HeartLight endoscopic ablation system for atrial fibrillation. The HeartLight device is the first of its kind to to allow...
View ArticleClik here to view.
Kinetic Concepts CEO named interim head of sister company LifeCell |...
Kinetic Concepts CEO named interim head of sister company LifeCell Kinetic Concepts president & CEO Joseph Woody was named interim CEO of LifeCell Corp. after ex-CEO Lisa Colleran’s departure to...
View ArticleClik here to view.
CardioFocus raises $11M in debt round | Wall Street Beat
CardioFocus added $11 million to its coffers in a round of debt financing from Oxford Finance and Silicon Valley Bank as it commercializes its HeartLight endoscopic ablation system overseas and winds...
View ArticleClik here to view.
CardioFocus launches new E.U. trial of HeartLight ablation system
Massachusetts-based medical device maker CardioFocus announced the launch of a new clinical trial of its HeartLight endoscopic ablation system for atrial fibrillation, this time spanning multiple...
View ArticleClik here to view.
CardioFocus raises $32m, inks Japanese distribution deal
CardioFocus this week reported a funding round worth nearly $32 million and said it inked a distribution deal in Japan for its HeartLight laser ablation system for treating atrial fibrillation....
View ArticleClik here to view.
Quanta portable dialysis device wins CE Mark | Medtech funding for the week...
Quanta wins CE Mark for portable dialysis device January 6, 2015 by Mark Hollmer Quanta Fluid Solutions said it nailed additional funding that boosted its recent investment round to $44 million. The...
View ArticleClik here to view.
HRS 2015: CardioFocus’s visually-guided laser balloon noninferior to standard...
Visually-guided laser balloon ablation is as effective as standard ablation in treating paroxysmal atrial fibrillation, researchers announced today at the Heart Rhythm Society’s annual meeting in...
View ArticleClik here to view.
FDA to review HeartLight visually-guided ablation device from CardioFocus
CardioFocus said today that the FDA accepted its pre-market approval application for the HeartLight visually-guided laser balloon ablation device for treating atrial fibrillation. The PMA bid, backed...
View ArticleClik here to view.
FDA clears CardioFocus’ HeartLight ablation system
CardioFocus said today it won FDA premarket approval for its HeartLight endoscopic ablation system, indicated for treating drug refractory recurrent symptomatic paroxysmal AF. The approval is based on...
View ArticleClik here to view.
CardioFocus readies HeartLight’s U.S. coming-out party at HRS 2016
Pre-market approval from the FDA in hand, CardioFocus is readying for a coming-out ball of sorts for its HeartLight cardiac visualization and ablation device at this week’s annual meeting of the Heart...
View ArticleClik here to view.
CardioFocus launches HeartLight in U.S.
CardioFocus said yesterday it launched its HeartLight endoscopic ablation system in the U.S., touting that the 1st commercial procedure with the device had been performed at New York City’s Mount Sinai...
View ArticleClik here to view.
CardioFocus launches next-gen HeartLight Exalibur balloon trial
CardioFocus said today it launched a clinical trial of its next-generation HeartLight Excalibur balloon device designed for pulmonary vein isolation procedures. The Marlborough, Mass.-based company...
View ArticleClik here to view.
CardioFocus raises $20m, looking for $12m more
UPDATED March 29, 2017, with comment from CardioFocus. CardioFocus raised $20.2 million in a new round of equity and options financing, according to an SEC filing posted this week. Money in the round...
View ArticleClik here to view.
CardioFocus launches 3 studies of HeartLight ablation system
CardioFocus today announced the launch of 3 studies of its HeartLight endoscopic ablation system, touting that over 1,000 patients with atrial fibrillation will be enrolled across the studies. The...
View Article
